WFIRM has also led two federal initiatives to regenerate tissues from battlefield injuries (AFIRM I and AFIRM II), with a combined funding of $160 million from the U.S. Department of Defense.
WFIRM's involvement in the development of treatments for combat injuries has led to the launch of two major federal programs, AFIRM I and AFIRM II, which together have secured $160 million in funding from the U.S. Department of Defense.